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Measurement of Rat Insulin 
Enzyme-Linked Immunosorbent Assay With 
Increased Sensitivity, High Accuracy, 
and Greater Practicability Than 
Established Radioimmunoassay 
JORN KEKOW, KARIN ULRICHS, WOLFGANG MULLER-RUCHHOLTZ, AND WOLFGANG L. GROSS 
Total immunoreactive insulin (IRI) is conventionally 
determined by radioimmunoassays. IR! measurement 
in rats can be made more sensitive, accurate, and 
practical, as demonstrated by a new modified 
enzyme-linked immunosorbent assay (ELlSA). It is 
characterized by indirect binding of an anti-insulin 
antibody by an antiglobulin antibody and uses the 
principle of competitive saturation. In this ELlSA, IRI 
can be determined in a wide range of concentrations, 
corresponding to the standards. The standard curve 
ranges from 100 to 0.049 ng/mllRI (1 ng/ml - 23.4 
JLU/ml - 172 pM rat insulin). The statistical analysis 
shows between- and within-assay coefficients of 
variation of :515%. Diabetes 37:321-26,1988 
Insulin secretion is a ~-cell-specific function. Yalow and Berson (1) were the first to develop a reliable method for determining this hormone in humans. Meanwhile, their radioimmunoassay (RIA) method is widely used in 
various modified forms (2). For research purposes, RIAs 
have been adapted for application in animals, with a species-
matched standard insulin preparation. In addition to in vivo 
experiments, insulin secretion can be evaluated in vitro with 
cultivated ~-cells or islets of Langerhans (3). Such experi-
ments are done preferentially in the rat model. 
We describe an enzyme-linked immunosorbent assay 
(ELlSA) for optimized detection of rat insulin (for principal 
considerations cf. refs. 4 and 5). The assay was developed 
to allow rat insulin to be determined in large numbers of 
specimens. We were especially interested in being able to 
detect extremely varied amounts of rat insulin, ranging from 
very small ones in sera to very high ones in culture super-
natants from islets. Emphasis was placed on readily usable 
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stable reagents. Previous work with a commercially available 
RIA (Novo, Bagsvaerd, Denmark) was not fully satisfactory 
because it was not sensitive enough when used with the 
serum quantities available in rats and because it depended 
on freshly 1251-labeled reagents. Another disadvantage of the 
RIA was the multiple dilution steps, costing time and re-
agents, that were necessary to fit high insulin concentrations 
in culture supernatants from islets to the range of the stan-
dard curve. 
MATERIALS AND METHODS 
The ELlSA described in this paper is based on the principle 
of competitive saturation of an anti-insulin antibody with 
either unlabeled or peroxidase-Iabeled insulin. 
Reagents. The rabbit anti-guinea pig antibody (antiglobulin 
antibody) used to fix the anti-insulin antibody to the microtiter 
plate was purchased from EY Laboratories (San Mateo, CA; 
cat. no. AT-2358). The antibody was obtained in an affinity-
purified quality and consisted of -1 mg of anti-guinea pig-
specific antibodies per milliliter. The anti-insulin antibody 
was produced by Novo (antibody M 8309). This antibody 
was generated in guinea pigs immunized with porcine in-
sulin. The undiluted guinea pig serum had a binding capacity 
of -3 U porcine insulin per milliliter. The rat standard was 
also provided by Novo. All experiments described herein 
were performed with this Novo standard, unless otherwise 
mentioned. To validate the ELlSA system, another standard 
was obtained from Lilly (Indianapolis, IN). 
The peroxidase-Iabeled insulin (conjugate) was from 
Sigma (St. Louis, MO; cat. no. 1-2133). It was prepared from 
bovine insulin, which was coupled via an N-hydroxysuc-
cinimide ester (6); 1.2 mol of horseradish peroxidase type 
VI (Sigma) was coupled with 1 mol of insulin. The commer-
cially available preparation used in our assay was provided 
in an affinity-purified quality and had a protein concentration 
of 1 mg/ml. The substrate for the enzyme reaction was 0-
phenylenediamine dihydrochloride (OPD; Fluka, Buchs, 
Switzerland). 
Specimens other than standards were sera from rats or 
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supernatants from islet cultures. The supernatants were har-
vested at the end of the incubation period by pipetting and 
stored in a refrigerator at - 20°C. Each specimen was as-
sayed in triplicate. 
Buffers. The coating buffer (0.05 M carbonate bicarbonate 
buffer, pH 9.6) used to attach the rabbit anti-guinea pig 
antibody to the polystyrene microtiter plates was made by 
dissolving 1.59 g of Na2C03 , 2.93 g of NaHC03 , and 0.20 g 
of NaN3 in 1 L of distilled water. The incubation buffer (0.04 
M phosphate buffer, pH 7.4) used to couple the anti-insulin 
antibody to the anti-guinea pig antibody was prepared by 
dissolving 5.77 g of Na2HP04 /2H20, 1.05 g of NaH2P04 /H20, 
1.00 g of bovine serum albumin (BSA) (RIA grade, Sigma), 
and 0.24 g of sodium merthiolate (Sigma, cat. no. T5125) in 
1 L of distilled water. The incubation buffer for the rat insulin 
standards or samples differed from the previous one in that 
0.6 g of NaCI and 5.9 g of BSA were added per 100 ml of 
the phosphate buffer. Thus, the buffer was isotonic to serum, 
the high albumin concentration mimicking the protein con-
centration of the serum (2). The washing buffer (0.15 M phos-
phate-buffered saline, pH 7.2) contained 8.0 g of NaCI, 0.2 
g of KCI, 1.15 g of Na2HP04 , 0.2 g of KH 2P04 , and 0.5 ml of 
Tween 20 (Merck, Darmstadt, FRG) in 1 L of distilled water. 
The substrate solution consisted of 20 mg of OPD and 0.15% 
H20 2 dissolved in enzyme buffer. This buffer (0.05 M) was 
al fa fa rabbit anti-guinea pig ab 
W guinea pig anti-insulin ab 
[j [j 
cl I I 
R insulin (unlabeled I 
0> ~~ '" I::::::] W 
d) I I 
~ insulin (peroxidase-Iabeled I 
.1 ~ ~ I 
o OPD (substrate) 
FIG. 1. Determination of rat insulin by ELISA. a: Coating of microtiter 
plate with antiglobulin antibody. b: Anti-insulin antibody is added 
and bound by antiglobulin antibody. c: Insulin (from sera, culture 
supernatants, or standard) is bound by anti-insulin antibody. d: 
Competitive saturation of anti-insulin antibody with either unlabeled 
or enzyme-Iabeled insulin. e: Measurement of substrate degradation 
after removal of all unbound insulin (Iabeled/unlabeled). For detailed 
procedure see MATERIALS AND METHODS. 
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FIG. 2. Typical standard curves. Curves A and B: anti-insulin antibody 
is coated directly onto microtlter plate without using antiglobulin 
antibody (dilution of anti-insulin antibody is 1:18,000 for curve Band 
1 :72,000 for curve AI. Curve C: optimization of standard curve by 
fixing anti-insulin antibody (dilution 1 :72,000) with antiglobulin 
antibody. Optical density (OD) is expressed as mean ~SD of triplicate 
samples. 
prepared by adjusting a sodium dihydrogen phosphate so-
lution (2.07 g of NaH2P04 in 300 ml of H20) to pH 5.6 by 
adding appropriate amounts of a disodium hydrogen phos-
phate solution (2.67 g of Na2HP04 /2H20 in 300 ml of H20). 
ELlSA. Figure 1 illustrates the individual steps that were 
performed. Microtiter plates with 96 round-bottomed wells 
(Nunc, Roskilde, Denmark) were coated by a sandwich prin-
ciple. First, the plates were coated with the rabbit anti-guinea 
pig antibody (antiglobulin antibody) at a pH of 9.6 in a 2-h 
incubation period at 37°C (150 fLl/well) (a). This antibody 
was used in a dilution of 1:1000. The plates were washed 
and then incubated with the 1 :72,000 diluted anti-insulin an-
TABLE 1 
Effect of various glucose concentrations on insulin secretion of rat 
islets cultured in CMRL medium with 10% fetal calf serum 
Glucose 
Islets (n) (mM) 
8 
4 
8 
7 
9 
4 
5 
5 
5 
20 
20 
20 
Insulin secretion 
Total 
(ng . ml- 1 • 24 h- 1) 
397 
620 
496 
4365 
4558 
2819 
Per islet 
(ng . ml- 1 • 24 h- 1) 
50 
155 
62 
623 
506 
705 
CMRL medium was from Gibco (Grand Island, NY; cat. no. 041-
1530); fetal calf serum was from Biochrom (West Berlin). 
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FIG. 3. Evaluation of optimum antiglobulin 
antibody dilution for assay. Optimum standard 
curve is achieved with antiglobulin antibody 
dilution of 1:1000. Higher dilutions result in 
lower optical density (OD) values, indicating 
incomplete binding of anti-insulin antibody and, 
consequently, less binding of enzyme-Iabeled 
insulin, 0.049 0.098 0.39 1.56 6.25 25 100 ng/ml 
tibody at a pH of 7.4 with the phosphate buffer containing 
1%0 BSA (100 ILl/well; b). This incubation step again lasted 
2 h at 3JDC. 
Appropriate standards were prepared, e.g., starting with 
100.0 ng/ml. The standards or the test samples (rat sera or 
the supernatants from cultivated rat islets) were all diluted 
appropriately in phosphate buffer containing 6% BSA and 
used in triplicate (100 ILl each/well). One hundred microliters 
of the standards or the test samples were added in triplicate 
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to the plates after free antibodies had been removed by 
repeated washings (Fig. 1 c). The plates were allowed to 
incubate overnight at 4°C. The next day, 100 ILl of a 1: 10,000 
dilution of the insulin peroxidase conjugate was added to 
each well without washing the plates (Fig. 1 d). The buffer 
used for dilution of the peroxidase-Iabeled insulin was iden-
tical to that used for diluting the standards. The incubation 
lasted for 4 h at 4°C. Then the plates were washed, and 100 
ILl/well OPO solution was added (Fig. 1 e). The enzyme re-
rat insulin 
FIG. 4. Evaluation of optimum anti-insulin 
antibody dilution for assay. High anti-insulin 
antibody concentrations result in higher optical 
density (OD) values, Indicating increased binding 
of enzyme-Iabeled insulin. Acceptable standard 
curve is achieved by anti-insulin antibody 
dilution of 1 :72,000. 0.049 0.098 D.39 1.56 6.25 25 100 ng/ml 
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TABLE 2 
Effect of administration of glucose (1 g/kg body wt, i.v.) on insulin secretion in Lew'ls rats 
Time (min) 
Experiment no. -10 +1 +2 +3 +4 +5 +10 +20 +30 +40 
1 * 1.6 4.7 4.5 6.0 4.3 3.3 0.9 0.7 0.7 0.6 
2* 0.7 7.8 10.3 6.4 5.6 4.4 2.3 1.9 1.6 0.8 
3t 0.7 12.0 6.0 1.7 1.3 0.8 0.5 0.5 1.2 1.9 
4t 56 34.1 11.7 6.8 5.3 9.7 11.7 7.2 11.8 3.5 
Values are insulin secretion in nanograms per milliliter. Specimens, either posthepatic (vena cava*) or prehepatic (vena portaet), were 
taken after various time intervals (min). 
action was stopped after 30 min by adding 100 f.ll of 0.5 M 
H2S04 per well, and the optical density (OD) was measured 
at 492 nm. The mathematical computations for the calcu-
lation of the specimens were done by infinitesimal approx-
imation. All washings were done with phosphate-buffered 
saline, pH 7.2. The plates were washed four times each with 
250 f.ll of buffer/well. All steps of this assay were performed 
with an ELlSA processor (Behring, Marburg, FRG) to guar-
antee reproducible assay conditions. 
To study the influence of the coating procedure, in one 
series the antiglobulin antibody (final dilutions 1 :18,000 and 
1 :72,000) was coated directly onto the microtiter plate at a 
pH of 9.6 in a 2-h incubation period at 37°C. In other words, 
step a was carried out with the anti-insulin antibody instead 
of the antiglobulin antibody, and step b was omitted. 
RESULTS 
For a high-quality ELlSA with an anti-insUlin antibody fixed 
to a solid phase and the principle of competitive saturation, 
optimum insulin binding to the anti-insulin antibody is es-
sential. In our assay the insulin-binding properties were im-
proved by fixing the anti-insulin antibody with an antiglobulin 
antibody. Fig. 2, curve C, illustrates a typical dose-response 
curve starting at 100 ng/ml rat insulin. The standard could 
be diluted down to a concentration of 0.049 ng/ml rat insulin, 
and the curves were clearly dose dependent. When only 
buffer was added instead of insulin standard, the OD was 
TABLE 3 
Accuracy of immunoreactive insulin measurement as shown by 
recovery study 
Set Standard Expected Measured Recovery 
no. Background added value value (%) 
5.7 10 15.7 13.7 80 
5.7 2.5 8.2 8.3 104 
5.7 0.6 6.3 6.5 133 
2 39.7 10 49.7 48.1 84 
39.7 2.5 42.2 43.8 164 
3 1.9 10 11.9 12.0 101 
1.9 2.5 4.4 4.8 116 
1.9 0.6 2.5 2.8 150 
4 2.4 10 12.4 14.6 122 
2.4 2.5 4.9 5.8 136 
2.4 0.6 3.0 3.4 166 
Values are nanograms of rat insulin per milliliter in a 1 :50 dilution 
(sets 1 and 2 of culture supernatants) or in a 1:5 dilution (sets 3 and 
4 of rat sera) of specimen. Relatively high serum levels were 
obtained from glucose-stimulated rats. Recovery = (measured 
value - background)/standard added. 
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:::::.804. The blanks (OD values when substrate or conjugate 
was omitted to prevent degradation of the substrate by the 
enzyme) were no higher than .007. This was also true of a 
standard curve for rat insulin omitting the anti-insulin anti-
body in the coating procedure. To demonstrate the efficiency 
of the indirect coating method, Fig. 2, curves A and B, show 
the standard curves that resulted when the anti-insulin anti-
body was coated directly onto the microtiter plates without 
using the antiglobulin antibody. These standard curves ex-
press only a poor increase in the OD in relation to the amount 
of insulin. Even a fourfold increase in concentration of the 
anti-insUlin antibody (Fig. 2, curve B) did not result in a 
standard curve like that seen with the indirect coating pro-
cedure (Fig. 2, curve C). 
Optimum dilutions for the antiglobulin antibody and the 
anti-insulin antibody were established separately. Figure 3 
demonstrates that a dilution of 1:1000 of the antiglobulin 
antibody resulted in sufficient binding of the anti-insUlin 
antibody. Higher concentrations of the antiglobulin antibody 
did not lead to a significant increase in the OD values, in-
dicating that in a 1: 1000 dilution the antiglobulin antibody 
fixes the anti-insulin antibody almost completely. When the 
concentrations of the anti-insulin antibody were changed, 
higher anti-insulin antibody concentrations resulted in higher 
OD values (Fig. 4). This is due to increased binding of per-
oxidase-Iabeled insulin to unsaturated anti-insulin antibod-
ies. Dilutions of <1 :72,000 did not show any considerable 
TABLE 4 
Variation within assays 
Detected (ng/ml) 
Expected (ng/ml) Mean Range SD CV (%) 
50 47.8 44.5-540 3.7 7.7 
25 26.9 24.2-29.5 2.5 9.5 
12.5 12.0 11.2-14.5 1.4 11.7 
6.25 5.3 5.0-6.2 0.5 9.4 
3.12 2.8 2.2-3.2 0.4 14.3 
1.56 1.4 1.3-1.6 0.14 10.0 
0.78 0.71 0.63-0.84 0.078 11.0 
0.39 0.33 0.29-0.41 0.044 13.3 
0.19 0.16 0.14-0.20 0.025 15.6 
0.098 0.096 0.084-0.121 0.010 10.4 
Values are results of 5 determinations done in triplicate in same run 
(identical samples were prepared from standard by serial dilutions 
in phosphate buffer containing 6% BSA). CV, coefficient of vari-
ation. 
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TABLE 5 
Variation between assays 
Detected (ng/ml) 
Expected (ng/ml) Mean Range SD CV (%) 
50 48.5 41.5~52.0 4.4 9.0 
25 25.7 22.7~27.0 1.8 7.0 
12.5 10.9 8.7~13.2 1.7 15.6 
6.25 5.5 4.7~6.0 0.5 9.1 
3.12 3.1 2.5~3.7 0.4 12.9 
1.56 1.4 1.3~1.6 0.15 10.7 
0.78 0.72 0.65~0.85 0.076 10.6 
0.39 0.32 0.29~0.42 0.050 15.6 
0.19 0.15 0.11~0.18 0.023 15.3 
0.098 0.099 0.085~0121 0.015 15.2 
Values are results of 5 determinations done in triplicate in 5 different 
experiments (identical samples were prepared from standard by 
serial dilutions in phosphate buffer containing 6% BSA). CV, coef-
ficient of variation. 
increase in the OD values, however. This indicates that nearly 
all peroxidase-Iabeled insulin had been bound to the anti-
insulin antibody when the standard concentrations were low. 
For reasons of economy and precision, we preferred to dilute 
the anti-insulin antibody 1 :72,000. 
For routine measuring of supernatants from cultivated rat 
islets, we used a standard curve ranging from 100 to 0.78 
ng/ml rat insulin. With a 1 :50 dilution for the culture super-
natants, it was possible to detect from 39.0 to 5000 ng/ml 
of insulin in one run. Table 1 shows an example of an in vitro 
experiment in which islets of Langerhans were stimulated for 
24 h. Depending on the glucose concentration of the culture 
medium, the values for the rat insulin in the supernatants 
ranged from 397 to 4558 ng/ml. For detecting insulin in rat 
sera, we preferred a standard curve ranging from 12.5 to 
0.049 ng/ml rat insulin. This means that for sera diluted 1 :5, 
FIG. 5. Comparison of standard curves from 
different rat standard preparations: Novo (e) and 
Lilly (_). OD, optical density. 
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FIG. 6. Comparison of standard curves for insulin from different 
species: rat insulin (e, Novo) and bovine insulin (_, Novo). OD, optical 
density. 
0.24~60.0 ng/ml of rat insulin could be detected. This was 
an appropriate approach for studying insulin secretion after 
glucose challenge in small-volume specimens. Data from a 
typical experiment are shown in Table 2. Dependent on the 
initial insulin levels and the veins from which the specimens 
were taken (pre- or posthepatic), varying insulin concentra-
insulin 
0.1 10 lOO ng/ml 
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tions could be detected, reaching a peak 1-3 min after glu-
cose administration. 
In accordance with the proposed application of the EL/SA, 
we performed a recovery study to validate the assay. The 
first part of the study (details in Table 3) consisted of ex-
periments (sets 1 and 2) in which different amounts of rat 
standard insulin were added to culture supernatants from 
rat islets diluted 1 :50. The second part of the study (sets 3 
and 4) was carried out with rat sera diluted 1 :5, containing 
1.9 or 2.4 ng/ml rat insulin. When we compared the expected 
values with the ones we measured, the recovery ranged from 
80 to 166%. Further statistical analysis showed that the de-
gree of precision was acceptable, with the between- and 
within-assay coefficients of variation :s15% (Tables 4 and 
5). In a study on the effect of serial dilution of sera or culture 
supernatants on the measured concentration of insulin, nei-
ther sera nor culture supernatants had an inhibitory or aug-
mentative effect. For sera run in a dilution from 1:8 to 1:1, 
the maximum coefficient of variation was 12.9%; culture su-
pernatants had a maximum coefficient of variation of 14% in 
serial dilutions running from 1:100 to 1 :800. 
To further validate the EL/SA, we compared two different 
rat standard preparations. Figure 5 shows the standard 
curves of a serial dilution starting from 100 ng/ml and end-
ing with 0.049 ng/ml for each standard preparation. The data 
in Fig. 5 were obtained from one run of a microtiter plate, 
each standard preparation covering one-half of the plate. 
The comparison of the OD values showed a high degree of 
correspondence between the standard from Novo and that 
from Eli Lilly. The discrepancies may not have any real sig-
nificance for the practical application of the EL/SA with re-
gard to possible variations caused, for instance, by the di-
lution of the standard preparations. In contrast to this 
experiment, Fig. 6 compares standard curves obtained with 
insulin from different species, in this case rat and bovine 
insulin. As expected from the origin of the anti-insulin anti-
body and the strong structural similarity between bovine and 
porcine insulin, the OD values obtained in the bovine insulin 
assay were lower than those obtained in the rat insulin assay. 
DISCUSSION 
We present an immunoenzyme method for measuring im-
munoreactive insulin in both rat sera and culture superna-
tants from rat islets. The assay is based on a solid-phase 
immunoenzyme technique and the principle of competitive 
saturation of an anti-insulin antibody with either unlabeled or 
peroxidase-Iabeled insulin. This technique presents an al-
ternative to previously reported EL/SA procedures for mea-
suring human insulin with two different anti-insulin antibod-
ies, one of them enzyme labeled (7-11). In such techniques, 
unspecific binding of the enzyme-Iabeled antibody to the 
unlabeled antibody can be a problem. 
A major difficulty, i.e., that of working in a solid phase, was 
overcome by fixing the anti-insulin antibody with a second 
antibody. This considerably increased the capacity to bind 
insulin, as shown in Fig. 2. The implication is that the anti-
insulin antibody appears to lose some of its structural integ-
rity when bound directly to the solid phase at a pH of 9.6. 
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Other groups have used various kinds of beads to immobilize 
the anti-insulin antibody (7-11). We prefer working with mi-
crotiter plates because they can be coated easily. In addi-
tion, fast processing and automatic pipetting, washing, and 
photometry are feasible. 
Concerning the quality of the EL/SA, the variation within 
and between tests and the results of the experiments to 
demonstrate accuracy achieve a standard that conforms to 
commercially available RIAs. Our technique employed in the 
rat system has the advantage of generating a standard curve 
with a broad range, which is hardly achieved by RIA. This 
means fewer errors due to frequent dilutions and greater 
practicability. 
Most important, the high degree of sensitivity allows more 
detailed time-kinetic studies of rat insulin in animals and 
corresponding in vitro experiments, because satisfactory 
measurements are now possible with small quantities of 
serum or supernatant. With the specimens being handled in 
the microtiter plate system and the lack of dependence on 
fresh radionucleotides, larger numbers of specimens can be 
processed at any given time. 
Commercially available reagents can be used throughout. 
The use of peroxidase-Iabeled insulin instead of 1251-labeled 
insulin is less expensive, and the laboratory equipment 
needed is less sophisticated. Therefore, with this assay, it 
is easier to perform detailed studies of !3-cell function in vivo 
and in vitro in the fields of diabetes and pancreas trans-
plantation research. 
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